Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 27;1(2):100034.
doi: 10.1016/j.jacadv.2022.100034. eCollection 2022 Jun.

Optimal Perfusion Targets in Cardiogenic Shock

Affiliations
Review

Optimal Perfusion Targets in Cardiogenic Shock

Rebecca Mathew et al. JACC Adv. .

Abstract

Cardiology shock is a syndrome of low cardiac output resulting in end-organ dysfunction. Few interventions have demonstrated meaningful clinical benefit, and cardiogenic shock continues to carry significant morbidity with mortality rates that have plateaued at upwards of 40% over the past decade. Clinicians must rely on clinical, biochemical, and hemodynamic parameters to guide resuscitation. Several features, including physical examination, renal function, serum lactate metabolism, venous oxygen saturation, and hemodynamic markers of right ventricular function, may be useful both as prognostic markers and to guide therapy. This article aims to review these targets, their utility in the care of patients with cardiology shock, and their association with outcomes.

Keywords: cardiogenic shock; lactate; mean arterial pressure; resuscitation; target.

PubMed Disclaimer

Conflict of interest statement

Dr Brodie has received research support from ALung Technologies; has been on the medical advisory boards for Abiomed, Xenios, Medtronic, Inspira, and Cellenkos; is the President-elect of the Extracorporeal Life Support Organization (ELSO); and is the Chair of the Executive Committee of the International ECMO Network (ECMONet). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
Central Illustration
Central Illustration
Clinical, Biochemical, and Hemodynamic Variables This figure highlights clinical, biochemical, and hemodynamic parameters that are commonly trending in the ongoing management of patients with cardiogenic shock. Arrows identify the direction of change in states of clinical deterioration. BP = blood pressure; CI = cardiac index; CPA = pulmonary artery compliance; CPO = cardiac power output; CRT = capillary refill time; eGFR = estimated glomerular filtration rate; HR = heart rate; JVP = jugular venous pressure; LC = lactate clearance; LVEDP = left ventricular end-diastolic pressure; MAP = mean arterial pressure; P(v-a)CO2 gap = venous arterial carbon dioxide gap; PAPi = pulmonary artery pulsatility index; PetCO2 = end-tidal CO2; sBP = systolic blood pressure; ScvO2 = central venous oxygen saturation; SvO2 = mixed venous oxygen saturation.

References

    1. Hochman J.S., Sleeper L.A., Webb J.G., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341(9):625–634. - PubMed
    1. De Backer D., Biston P., Devriendt J., et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779–789. - PubMed
    1. Levy B., Clere-Jehl R., Legras A., et al. Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2018;72(2):173–182. - PubMed
    1. TRIUMPH Investigators. Alexander J.H., Reynolds H.R., et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA. 2007;297(15):1657–1666. - PubMed
    1. Felker G.M., Benza R.L., Chandler A.B., et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J Am Coll Cardiol. 2003;41(6):997–1003. - PubMed

LinkOut - more resources